Pilot Study: Fenofibrate for Patients With Primary Biliary Cirrhosis and An Incomplete Response To Ursodeoxycholic Acid Academic Article uri icon

abstract

  • Newer therapies are needed for patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid (UDCA). Fenofibrate is a fibric acid postulated to regulate immune response and cell proliferation.

publication date

  • 2011-01-01